Biotech

All Articles

Praxis epilepsy drug lessens seizures in stage 2 trial

.Praxis Preciseness Medicines has scored yet another midphase gain in epilepsy this year, along with...

Three officers resign as Dyne articles blended data for DMD applicant

.After getting away from a scientific grip several years back, Dyne Rehab has shown new stage 1/2 in...

Arrowhead fires off stage 3 information in uncommon metabolic health condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own give ahead of a possible face-off with Ionis, relea...

Pfizer, Valneva present lyme health condition go reliable for 2nd booster

.Pfizer and Valneva may have regarding 2 even more years to hang around prior to they create the 1st...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a talk along with Ayla Ellison, Ferocious Biotech Editor-in-Chief and also Michelle...

New records show how Bayer's asundexian fell short to avoid strokes

.Bayer suspended the phase 3 trial for its own factor XIa inhibitor asundexian behind time in 2014 a...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its own numerous sclerosis (MS) med tolebrutinib to the FDA, execu...

Galapagos' stockpile as fund shows intent to mold its own progression

.Galapagos is happening under extra pressure from investors. Having actually built a 9.9% risk in Ga...

Cell- concentrated Sana gathers initial CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings as ...

Allist pays off Jacobio $21M, landing job in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has actually bought on its own a starring role in China's KRAS mark...